meda.se
Investors - Meda
http://www.meda.se/investors
Manufacturing and Supply Chain. Meda’s share has been quoted on the Stockholm Stock Exchange since 1995 and on the NASDAQ OMX Nordic Exchange in Stockholm (Large Cap segment ) since 2006. The share is delisted since August 24, 2016. Meda's Annual Report 2015. Bulletin from the extraordinary general meeting in Meda AB (publ). Delisting of Meda Aktiebolag (publ). Notice to noteholders regarding change of control. Interim Report, January-June 2016. Interim Report, January-March 2016. MEDA AGM 14th APRIL 2016.
meda.se
Respiratory - Meda
http://www.meda.se/product-portfolio/respiratory
Manufacturing and Supply Chain. Allergies and asthma are among the most common chronic conditions globally, ranging from manageable to life-threatening. Allergies in particular are on the rise: in 2015 close to 50% of the world population was affected by some form of allergy, while severe allergic reactions (anaphylaxis) have increased several-fold in the past decade. The cornerstone in asthma therapy is effectively treating the underlying chronic inflammation with inhaled corticosteroids while minimizin...
meda.se
Sitemap - Meda
http://www.meda.se/sitemap
Manufacturing and Supply Chain. Manufacturing and Supply Chain. Meda has a well-diversified product portfolio, a global presence, and is represented within all areas of pharmaceuticals: Specialty Products, Cx, and OTC. CB12 is a powerful, unique and patented mouth rinse that ensures not only first class breath, but also provides a daily shot of confidence. Every day and all day CB12 provides 12 hours of protection. EndWarts is an effective treatment for self-removal of warts on hands, feet and the body.
meda.se
Calendar - Meda
http://www.meda.se/investors/calendar
Manufacturing and Supply Chain. Interim report January March. Interim report, January June. Interim report January September. AAAAI American Academy of Asthma, Allergy and Immunology, Houston, TX. ESCEO Congress in Milan. Interim report, January-March 2015. Meda s Capital Markets Day. ATS American Thoracic Society, Denver, CO. Interim report, January-June 2015. 24th EADV, Copenhagen, Denmark. CHEST American College of Chest Physicians, Montreal, Canada. 11th EADO, Marseille, France. May 16th - 21th.
meda.se
Rottapharm Acquisition - Meda
http://www.meda.se/investors/rottapharm-acquisition
Manufacturing and Supply Chain. Meda’s acquistion of Rottapharm Madaus completed. Below aggregated, published information about the whole acquisition links. Meda to acquire Rottapharm, Webcast July 31st 10 am CET. Meda’s acquisition of Rottapharm completed and the rights issue of SEK 2 billion is launched, October 10th. Press release, July 31st. Webcast, July 31st. Presentation, July 31st. Meda EGM, Thursday November 6th at 1 pm. We also have national marketing sites. Links to these are under Meda Wo...
meda.se
Rights issue - Meda
http://www.meda.se/investors/rights-issue
Manufacturing and Supply Chain. Meda has a well-diversified product portfolio, a global presence, and is represented within all areas of pharmaceuticals: Specialty Products, Cx, and OTC. CB12 is a powerful, unique and patented mouth rinse that ensures not only first class breath, but also provides a daily shot of confidence. Every day and all day CB12 provides 12 hours of protection. EndWarts is an effective treatment for self-removal of warts on hands, feet and the body. Box 906, SE-170 09 Solna,. No ac...
meda.se
Pain and Inflammation - Meda
http://www.meda.se/product-portfolio/pain-and-inflammation
Manufacturing and Supply Chain. Pain may not be a primary issue but can be a life-disrupting symptom of an inflammatory disease, since many organs do not have many pain-sensitive nerves. Treatment of organ inflammation is directed at the cause of inflammation whenever possible, while relieving the most disrupting symptoms for the patient. Pain and Inflammation products. Rheumon (Etofenamate) is a non-steroidal anti- inflammatory drug (NSAID) for topical or intra-muscular administration. NSAIDs reliev...
meda.se
Newsroom - Meda
http://www.meda.se/newsroom
Manufacturing and Supply Chain. Bulletin from the extraordinary general meeting in Meda AB (publ). Delisting of Meda Aktiebolag (publ). Notice to noteholders regarding change of control. Mylan Completes Acquisition of Meda. Meda Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting. Extraordinary General Meeting of Meda Aktiebolag (publ). Interim Report, January-June 2016. Meda’s second quarter 2016 report. Interim Report, January-March 2016. Meda AB (publ) AGM bulletin.
meda.se
Board of Directors - Meda
http://www.meda.se/corporate-governance/board-of-directors
Manufacturing and Supply Chain. Annual General Meeting (AGM). Education: BSc Business and Economics. Board member since: 2014. CEO of Stena Adactum AB and Stena Sessan AB. Chairman of the board of Gunnebo AB, Ballingslöv International AB, Envac AB and Stena Renewable AB. Board member of Stena Adactum AB and Stena Sessan Rederi AB. Shares in Meda: 40 016. Board member and deputy chairman. Board member since: 2014. Shares in Meda: 33,016,286. Controlled through closely related company). Shares in Meda: 0.
